DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the APRAMEYA ENGINEERING LTD (APRAMEYA) share price today?

APRAMEYA ENGINEERING LTD (APRAMEYA) is trading at ₹147 on the NSE, down 1.97% on the day. Source: DocStoX.

What is the PE ratio of APRAMEYA ENGINEERING LTD?

APRAMEYA ENGINEERING LTD has a price-to-earnings (PE) ratio of 17.4 in the Healthcare sector.

What is the market capitalisation of APRAMEYA ENGINEERING LTD?

APRAMEYA ENGINEERING LTD has a market capitalisation of approximately ₹0 crore.

APRAMEYA ENGINEERING LTD

APRAMEYA·NSE·Healthcare

₹147.00▼ -2.95 (-1.97%)

Healthcare · Medical Equipment & Supplies

Revenue under pressure recently

Day₹147.00

₹158.35

52W₹140

₹3603%

Open

₹147.10

High

₹158.35

Low

₹147.00

Prev Close

₹149.95

Volume

7.0K

VWAP

₹148.91

Snapshot

Key fundamentals

Market Cap

₹0 Cr

P/E Ratio

17.36Fair

P/B Ratio

4.03

EPS

₹8.47

Book Value

₹36.45

ROE

7.54%Weak

ROCE

31.12%Efficient

Dividend Yield

0.00%

Debt / Equity

0.10Low

Face Value

₹10.00

52W High

₹360.00

52W Low

₹140.25

Sector

Healthcare

Industry

Medical Equipment & Supplies

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹70

▼ 52.6%downside

Trading at ₹147 — 53% above our estimate

BearFair valueBull

₹59₹70₹83

/100

Business quality — Watch the fundamentals

Growth 0Profitability 34Efficiency 50Valuation 88

Plain English

Our view

Revenue under pressure recently
Low debt relative to equity
Weak returns on equity (8%)

Strengths

Low debt relative to equity
Capital is working hard (ROCE 31%)
Promoters hold a controlling stake

Risks

Weak returns on equity (8%)
Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

25% ROE fading to 12% over ~10 yrs, on ₹36 book

₹66

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹83

Analyst target

No analyst coverage

—

Blended fair value₹70

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 31%)
Promoters hold a controlling stake

Bear case

Weak returns on equity (8%)
Revenue has been shrinking
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

17.4Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

7.5%Weak

Above 15% is considered healthy for Indian equities

ROCE

31.1%Efficient

Above 18% means capital is working hard

Debt/Eq

0.10Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

—

P/B

4.03

EPS

₹8.47

Div Yield

—

What changed

Recent changes

Promoters+0.52% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 17.4×

Growth

Shrinking

-11% rev CAGR

Profitability

Modest

7.5% ROE

Financial health

Rock solid

D/E 0.10

Momentum

N/A

No technicals

Today

Trading activity

Delivery %100.0%

Turnover₹10.42L Cr

Trades4

VWAP₹148.91

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-11.0%

+16.3%

10Y

—

Profit

-2.2%

+42.8%

10Y

—

EPS

—

10Y

—

Profile

Pros

Company has reduced debt.

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has high debtors of 368 days.
Company's cost of borrowing seems high
Working capital days have increased from 232 days to 377 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.52 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

74%

Promoter

Promoters

74.0%+0.52

Public

25.2%-0.46

FII / FPI

0.0%0.00

DII

0.7%-0.07

Total shareholders

933+111 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter74.05%

DII0.70%

Public25.24%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions